Why Invest in Orthofix

Improving commercial execution, differentiated growth platforms and disciplined financial management are strengthening Orthofix’s path to profitable growth and sustainable cash generation.

Orthofix is advancing from operational stabilization toward value creation through improving commercial execution, differentiated positions across attractive and growing musculoskeletal markets and a disciplined focus on profitability and cash generation. As execution improves, management believes Orthofix is positioned to deliver sustainable growth, expanding margins and stronger free cash flow generation over time.

1. Differentiated positions across attractive musculoskeletal markets
   Orthofix combines category leadership positions in Therapeutic Solutions and Biologics with differentiated platforms in Limb Reconstruction, Spine Fixation and Enabling Technologies. Together, these businesses provide exposure to an approximately $16 billion addressable market while creating multiple opportunities to drive growth, expand margins and strengthen cash generation over time. The company's portfolio includes the market-leading bone growth stimulation franchise and differentiated technologies across musculoskeletal care, providing multiple pathways for long-term value creation.
2. Improving commercial execution and growth quality
   Orthofix is building a higher-quality commercial model through greater sales productivity, a stronger distributor network and more disciplined allocation of commercial resources. The company is focused on improving execution consistency across key growth platforms while prioritizing opportunities with the highest potential returns.
3. Targeted innovation where Orthofix can lead
   Orthofix is investing in differentiated technologies, procedural solutions and targeted market-development opportunities that build on existing clinical expertise and commercial access. These investments are designed to support adoption, expand share in attractive categories and strengthen long-term growth across the company's key platforms.
4. A clearer path to profitability and cash generation
   Orthofix is pairing growth initiatives with disciplined cost management, working-capital improvement and rigorous capital allocation. The objective is to convert stronger commercial execution into sustained EBITDA growth, expanding margins and positive free cash flow.

Orthofix offers investors a focused musculoskeletal platform with multiple growth drivers, improving commercial execution and a disciplined path toward higher profitability and stronger free cash flow generation. The investment opportunity is not simply portfolio breadth. It is the potential for improving execution, differentiated growth platforms and disciplined financial management to create a stronger, higher-quality medtech company capable of generating sustainable long-term shareholder value.